1. Home
  2. LGND vs TRIP Comparison

LGND vs TRIP Comparison

Compare LGND & TRIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • TRIP
  • Stock Information
  • Founded
  • LGND 1987
  • TRIP 2000
  • Country
  • LGND United States
  • TRIP United States
  • Employees
  • LGND N/A
  • TRIP N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • TRIP Computer Software: Programming Data Processing
  • Sector
  • LGND Health Care
  • TRIP Technology
  • Exchange
  • LGND Nasdaq
  • TRIP Nasdaq
  • Market Cap
  • LGND 2.3B
  • TRIP 2.0B
  • IPO Year
  • LGND 1992
  • TRIP 2011
  • Fundamental
  • Price
  • LGND $120.43
  • TRIP $13.49
  • Analyst Decision
  • LGND Strong Buy
  • TRIP Hold
  • Analyst Count
  • LGND 6
  • TRIP 15
  • Target Price
  • LGND $145.00
  • TRIP $18.60
  • AVG Volume (30 Days)
  • LGND 107.6K
  • TRIP 1.5M
  • Earning Date
  • LGND 11-07-2024
  • TRIP 02-12-2025
  • Dividend Yield
  • LGND N/A
  • TRIP N/A
  • EPS Growth
  • LGND 160.46
  • TRIP N/A
  • EPS
  • LGND 2.47
  • TRIP 0.26
  • Revenue
  • LGND $152,422,000.00
  • TRIP $1,814,000,000.00
  • Revenue This Year
  • LGND $26.86
  • TRIP $4.08
  • Revenue Next Year
  • LGND $13.16
  • TRIP $6.23
  • P/E Ratio
  • LGND $48.80
  • TRIP $51.97
  • Revenue Growth
  • LGND N/A
  • TRIP 3.54
  • 52 Week Low
  • LGND $67.53
  • TRIP $12.93
  • 52 Week High
  • LGND $129.90
  • TRIP $28.76
  • Technical
  • Relative Strength Index (RSI)
  • LGND 52.94
  • TRIP 39.24
  • Support Level
  • LGND $113.39
  • TRIP $13.35
  • Resistance Level
  • LGND $124.03
  • TRIP $14.00
  • Average True Range (ATR)
  • LGND 5.31
  • TRIP 0.41
  • MACD
  • LGND -0.50
  • TRIP -0.02
  • Stochastic Oscillator
  • LGND 48.65
  • TRIP 10.37

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About TRIP TripAdvisor Inc.

Tripadvisor is the world's leading travel metasearch company. Its platform offers 1 billion reviews and information on about 8 million accommodations, restaurants, experiences, airlines, and cruises. In 2023, 58% of revenue came from the company's core Brand Tripadvisor segment, which includes hotel revenue generated through advertising on its metasearch platform. Viator, its experiences brand, was 41% of sales in 2023, and TheFork, its dining brand, represented 9% of revenue (about 8% of sales were intersegment, which are eliminated from consolidated revenue).

Share on Social Networks: